Michael Retchin

Michael Retchin is a serial biotech entrepreneur, deeply involved in fostering innovation and community within the life sciences sector. He founded NewCo, a venture focused on scientific intelligence and autonomous agents for biomedical knowledge, and played a foundational role at Cellarity, a biofirm developing cell-centric medicines. His entrepreneurial spirit is also evident in his co-founding of Nucleate, a global organization empowering emerging biotech leaders. michael+3

As a computational biologist and machine learning researcher, Michael is at the forefront of applying AI to drug discovery. His PhD research at Memorial Sloan Kettering Cancer Center, in the Chodera Lab, involves developing machine learning tools for small molecule drug discovery and building autonomous agents. He is also a co-author of the 'DrugGym' paper, which explores a testbed for the economics of autonomous drug discovery. mskcc+3

Michael is an active investor in the biotech space, having served as a Senior Associate at Pillar VC and a 'tiny investor' in Valthos, a biodefense company. His engagement in the investment side of biotech complements his entrepreneurial and scientific endeavors, demonstrating a holistic approach to advancing the field. nitter+1